UW Research

March 18, 2020

NIH: Availability of Administrative & Revision Supplements for COVID-19 Research

NIH Announces Availability of Supplements on COVID-19

The National Heart, Lung, and Blood Institute (NHLBI) issued a notice to highlight the urgent need for research on COVID-19 and on the biological effects of SARS-CoV-2.

Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

NOT-HL-20-757:
Notice of Special Interest (NOSI) – Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)